News or noise?

Article Abstract:

More questions are raised about the level and quality of the information disclosed to the market by the biotech managers and directors, who jump to make the most of the revival of investor interest in the biotech sector. Announcements by some small science companies listed on the Australian Stock Exchange, suggest that some directors have liberally interpreted their disclosure requirements.

United States, Forecasts and trends, Market trend/market analysis

---

Testing positive

Article Abstract:

Proteome Systems, a biotechnology company based in Australia, is back on revival path, after having seen the worst in 2005 when it saw its sales and valuations drop drastically. The company is developing a tuberculosis diagnostic device, the results of which have been quite good.

Sales, profits & dividends, Company sales and earnings, Company earnings/profit, Company business forecast/projection, Company forecasts, Proteome Systems Ltd.

---

Bio's flu worsons

Article Abstract:

The trends in stock rates in biotechnology industries in Australia are discussed.

Securities issued, listed, Securities, Company securities, Industry forecasts

Similar abstracts:

• Abstracts: New world disorder. Who's Hu. Middle-class kingdom
• Abstracts: Neurocrine Biosci. Neurocrine Biosciences
• Abstracts: New lease on life. All's well that ends. Off the plan
• Abstracts: A recipe for bad apples. Business lessons
• Abstracts: Paramount issues. Bird flu bungle. David Knott's missing chapter

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.